These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 9509068

  • 1. Combination therapy with GH and cyproterone acetate does not improve final height in boys with non-GH-deficient short stature.
    Kawai M, Momoi T, Yorifuji T, Muroi J, Yamanaka C, Sasaki H, Furusho K.
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):53-7. PubMed ID: 9509068
    [Abstract] [Full Text] [Related]

  • 2. Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency.
    Kawai M, Momoi T, Yorifuji T, Yamanaka C, Sasaki H, Furusho K.
    J Pediatr; 1997 Feb; 130(2):205-9. PubMed ID: 9042121
    [Abstract] [Full Text] [Related]

  • 3. Analysis of bone age maturation and growth velocity in isolated growth hormone (GH) deficient boys with and without gonadal suppression treatment and in GH deficient boys with associated gonadotropin deficiency.
    Satoh M, Tanaka T, Hibi I.
    J Pediatr Endocrinol Metab; 1997 Feb; 10(6):615-22. PubMed ID: 9467132
    [Abstract] [Full Text] [Related]

  • 4. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children.
    Hibi I, Tanaka T, Tanae A, Kagawa J, Hashimoto N, Yoshizawa A, Shizume K.
    J Clin Endocrinol Metab; 1989 Aug; 69(2):221-6. PubMed ID: 2526818
    [Abstract] [Full Text] [Related]

  • 5. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R, Gunczler P.
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [Abstract] [Full Text] [Related]

  • 6. Relationships between puberty and growth at adolescence in growth-hormone-deficient males: effect of growth hormone and of associated gonadal suppression therapy.
    Tanaka T, Yoshizawa A, Tanae A, Hibi I, Shizume K.
    Horm Res; 1990 Aug; 33 Suppl 4():102-5. PubMed ID: 2147164
    [Abstract] [Full Text] [Related]

  • 7. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 8. GH and GnRH analog treatment in children who enter puberty at short stature.
    Tanaka T, Satoh M, Yasunaga T, Horikawa R, Tanae A, Hibi I.
    J Pediatr Endocrinol Metab; 1997 Feb; 10(6):623-8. PubMed ID: 9467133
    [Abstract] [Full Text] [Related]

  • 9. Final height in non-growth hormone deficient children treated with growth hormone. The Italian Multicentre Study Group.
    Bernasconi S, Street ME, Volta C, Mazzardo G.
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):261-6; discussion 267. PubMed ID: 9373443
    [Abstract] [Full Text] [Related]

  • 10. Combined GH and LHRH analog treatment in short children.
    Tanaka T, Satoh M, Hibi I.
    Endocr J; 1996 Oct; 43 Suppl():S13-7. PubMed ID: 9076337
    [Abstract] [Full Text] [Related]

  • 11. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM, Boersma B, de Muinck Keizer-Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ, Rikken B.
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [Abstract] [Full Text] [Related]

  • 12. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.
    Kamp GA, Waelkens JJ, de Muinck Keizer-Schrama SM, Delemarre-Van de Waal HA, Verhoeven-Wind L, Zwinderman AH, Wit JM.
    Arch Dis Child; 2002 Sep; 87(3):215-20. PubMed ID: 12193430
    [Abstract] [Full Text] [Related]

  • 13. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
    Almeida MQ, Brito VN, Lins TS, Guerra-Junior G, de Castro M, Antonini SR, Arnhold IJ, Mendonca BB, Latronico AC.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394
    [Abstract] [Full Text] [Related]

  • 14. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.
    Tanaka T, Satoh M, Yasunaga T, Horikawa R, Tanae A, Katsumata N, Tachibana K, Nose O, Hibi I.
    Acta Paediatr Suppl; 1999 Feb; 88(428):85-8. PubMed ID: 10102060
    [Abstract] [Full Text] [Related]

  • 15. Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone.
    Chen YD, Shu SG, Chi CS.
    Acta Paediatr Taiwan; 2001 Feb; 42(5):291-6. PubMed ID: 11729706
    [Abstract] [Full Text] [Related]

  • 16. Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature.
    Loche S, Cambiaso P, Setzu S, Carta D, Marini R, Borrelli P, Cappa M.
    J Pediatr; 1994 Aug; 125(2):196-200. PubMed ID: 8040761
    [Abstract] [Full Text] [Related]

  • 17. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A, Simon D, Czernichow P.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [Abstract] [Full Text] [Related]

  • 18. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R.
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [Abstract] [Full Text] [Related]

  • 19. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature.
    Wit JM, Kamp GA, Rikken B.
    Pediatr Res; 1996 Feb; 39(2):295-302. PubMed ID: 8825803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.